Article thumbnail

Chinese Herbal Formula Xiao Yao San for Treatment of Depression: A Systematic Review of Randomized Controlled Trials

By Yuqing Zhang, Mei Han, Zhijun Liu, Jie Wang, Qingyong He and Jianping Liu


Objectives. To assess the beneficial and adverse effects of Xiaoyaosan for depression. Search Strategy. Electronic databases were searched until December 2009. Inclusion Criteria. We included randomized clinical trials testing Xiaoyaosan against placebo, antidepressants, or combined with antidepressants against antidepressants alone. Data Extraction and Analyses. Study selection, data extraction, quality assessment, and data analyses were conducted according to the Cochrane standards. Results. 26 randomized trials (involving 1837 patients) were included and the methodological quality was evaluated as generally low. The pooled results showed that Xiaoyaosan combined with antidepressants was more effective in comprehensive effect, the score of HAMD and the score of SDS compared with antidepressants alone. Xiaoyaosan was superior to antidepressants for the score of HAMD. However, Xiaoyaosan was not different from placebo for the score of SDS. There was no adverse effects reported in the trials from Xiaoyaosan. Conclusions. Xiaoyaosan appears to be effective on improving symptoms in patients with depression. However, due to poor methodological quality in the majority of included trials, the potential benefit from Xiaoyaosan need to be confirmed in rigorous trials and the design and reporting of trials should follow international standards

Topics: Review Article
Publisher: Hindawi Publishing Corporation
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (1999). Awareness, diagnosis, and treatment of depression,”
  2. (2004). Chinese herbal medicine for severe acute respiratory syndrome: a systematic review and meta-analysis,”
  3. (2005). Clinical comparative study of Amitriptyline and SSRIs and SSRIs combined with Chinese medicine or Tibetan drugs in treating senile depression in plateau district,”
  4. (2007). Clinical observation of combination therapy of western and traditional Chinese medicine for treatment of depression,”
  5. (2008). Clinical observation of integrative Chinese and Western medicine on treatment of depression,”
  6. (2005). Clinical observation of shugan jieyu prescription in treating depression,”
  7. (2008). Clinical observation on 45 cases of depression treated by soothing stagnation and invigorating blood circulation,”
  8. (2007). Clinical observation on effect of Danzhi Xiaoyao powder in treating depression,”
  9. (2006). Clinical study on effect of fluoxetine combined with Chinese medicine or tibetan drugs in treating senile depression in plateau district,”
  10. (1996). Comparative study of amitriptyline compared with amitriptyline combined with xiaoyao powder fortreatmentofdepression,”SichuanMentalHealth,vol.9,no. S1,
  11. Depression patients exceeding 26 million in China,”
  12. Depression sufferers grow in China,” China daily, content 422677.htm.
  13. (2007). Effe c to fD a n z h iX i a o y a o powder on neuro-immuno-endocrine system in patients with depression,”
  14. (1995). Health-related quality of life in primary care patients with mental disorders: results from the PRIME-MD 1000 study,”
  15. (2001). Modified danzhixiaoyao decoction treating 34 patients with depression,”
  16. (2007). The clinical controlled study of Xiaoyaowan plus citalopram treating patients with depression,”
  17. (2001). The clinical controlled study of Xiaoyaowan plus Doxepin treating masked depression,”
  18. (2008). The clinical observation of Imipramine combined with xiaoyaowan treating depression,” S i c h u a nM e n t a lH e a l t h ,
  19. (2000). The clinical observation on 36 patients with depression using combination of Chinese medicine and western medicine,”
  20. (2004). The clinical observation on depression with fluoxetine and xiaoyaowan,”
  21. (2008). The clinical observation on depression with modified xiaoyao powder,”
  22. (2002). The clinical observation on depression with xiaoyaowan and Venlafaxine,”
  23. (2004). The clinical observation on guipixiaoyaowan treating 100 patients with depression,”
  24. (2007). The clinical observation on modified xiaoyaosan and Amitriptyline treating 33 patients with depression,”
  25. (2007). The clinical observation on patients with depression using DanzhiXiaoyao decoction and fluoxetine,”
  26. (2008). The clinical research of depressive dsorder dreated
  27. (2009). Treatment of 41 patients with depression of liver-qi stagnation and spleen-deficiency type using xiaoyaosan and fluoxetine hydrochloride,”
  28. (2008). Treatment of depression of liver-qi stagnation and spleen-deficiency type with therapy of soothing liver and invigorating spleen,”
  29. (2005). W a n g ,Q .Z .L i u ,W .G .L i u ,C .Z .L i u ,a n dH .L .C h e n , “Therapeutic effect of doxepin combined with xiaoyao pill compared with fluoxetine for treatment of senile depression,”
  30. (1996). WHO collaborative study on impairments and disabilities associated with schizophrenic disorder,”
  31. (1980). WHO collaborative study onimpairments and disabilities associated with schizophrenic disorder,”
  32. (1999). Xiaoyao powder for treatment of 30 patients with depression,”